Search
for
Sort by
Research 31–60 of 1000+
- Comparative efficacy of topical finasteride (0.25%) in combination with minoxidil (5%) against 5% minoxidil or 0.25% finasteride alone in male androgenetic alopecia: A pilot, randomized open-label study
- Single-Nucleus and Bulk RNA Sequencing Reveals the Involvement of Natural Killer and CD8+ T Cells in the Progression of Androgenetic Alopecia
- A Retrospective Study on Integrative Management of Androgenic Alopecia with Individualized Homoeopathy, Xogen Therapy and Lifestyle Optimization- A Case Series
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Objective outcome measures: Collecting meaningful data on alopecia areata
- Central hair loss in African American women: Incidence and potential risk factors
- The pharmacology of methotrexate
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- The prevalence and types of androgenetic alopecia in Korean men and women
- Medical and Environmental Risk Factors for the Development of Central Centrifugal Cicatricial Alopecia
- The association of androgenetic alopecia and insulin resistance is independent of hyperandrogenemia: A case-control study
- Factors affecting the severity of central centrifugal cicatricial alopecia
- Association between androgenetic alopecia and cardiovascular risk factors according to BASP classification in Korean androgenetic alopecia
- Interventions for androgenic alopecia in women
- Androgenetska alopecija u žena
- Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss).
- Tissue Expansion in Cicatricial Alopecia
- Versatility of autologous growth factor concentrate therapy in early-stage androgenetic alopecia: A case report
- The Comparison of Metabolic Syndrome Parameters, Trichoscopic and Trichoscan Characteristics in Androgenetic Alopecia (AGA) and Early-Onset Androgenetic Alopecia (Early-Onset AGA)
- Metabolic Syndrome in Androgenetic Alopecia in a Tertiary Care Centre in Goa: A Case Control Study During COVID-19 Pandemic
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Guidelines for the management of alopecia areata
- Treatment of hyperandrogenic alopecia in women
- Systemic treatments for alopecia areata: A systematic review
- Study of the efficacy of carboxytherapy in alopecia
- Relationship between androgenetic alopecia and cardiovascular risk factors according to BASP classification in Koreans
- Physiology and Medical Treatments for Alopecia
- Development of fluridil, a topical suppressor of the androgen receptor in androgenetic alopecia
- Evaluation of efficacy of QR 678 and QR678 neo hair growth factor formulation for the treatment of female pattern alopecia in patients with PCOS—A prospective study
- Androgenetic alopecia (male pattern hair loss) in the United States: What treatments should primary care providers recommend?